A Phase 1, Open Label, Single Dose, Bioavailability Study In Healthy Volunteers Comparing PF-05089771 TS Oral Dispersion To PF-05089771 TS Capsule
Latest Information Update: 19 Dec 2012
Price :
$35 *
At a glance
- Drugs PF 5089771 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 30 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Sep 2012 New trial record